Physical considerations on discrepancies in target volume delineation

Zeitschrift fur Medizinische Physik

Volumn 19, Issue 4, 2009, Pages 224-235

  Moeckli, Raphaël ^a   Jeanneret Sozzi, Wendy ^b   Mirimanoff, René Olivier ^b   Ozsahin, Mahmut ^b   Zouhair, Abderrahim ^b   Valley, Jean François ^a   Bochud, François ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

discrepancies; head and neck; prostate; Volume delineation

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; INTERRATER RELIABILITY; INTRARATER RELIABILITY; PROSTATE ADENOCARCINOMA; RADIATION DOSE DISTRIBUTION; TONGUE CARCINOMA; TUMOR VOLUME;

HEAD AND NECK NEOPLASMS; HUMANS; MALE; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; SENSITIVITY AND SPECIFICITY; SWITZERLAND; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70749112830     PISSN: 09393889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.zemedi.2009.06.006     Document Type: Article

References (48)

1. Ahnesjö A. Collapsed cone convolution of radiant energy for photon dose calculation in heterogeneous media. Medical Physics 16 (1989) 577-592
2. Alber M. Normal tissue dose-effect models in biological dose optimisation. Z Med Phys 18 2 (2008) 102-110
3. Austin-Seymour A., Chen G.T.Y., Rosenman J., et al. Tumor and target delineation: current research and future challenges. Int J Radiation Oncology Biol Phys 33 5 (1995) 1041-1052
4. Beckendorf V., Bachaud J.M., Bey P., et al. Delineation of target volumes and organs at risk in conformal radiotherapy for the prostate cancer: French trial of dose escalation. Cancer/Radiothérapie 6 Supp. 1 (2002) S78-S92 (in French)
5. Brahme A., and Agren A.K. Optimal dose distribution for eradication of heterogeneous tumours. Acta Oncol 26 (1987) 377-385
6. Burman C., Kutcher G.J., Emami B., et al. Fitting normal tissue tolerance data to analytic function. Int J Radiation Oncology Biol Phys 21 (1991) 123-135
7. Cazzaniga L.F., Marioni M.A., Bossi A., et al. Interphysician variability in defining the planning target volume in the irradiation of prostate and seminal vesicles. Radiother Oncol 47 (1998) 293-296
8. Chen G.T.Y. Dose volume histograms in treatment planning. Int J Radiation Oncology Biol Phys 14 (1988) 1319-1320
9. Chetty I.J., Curran B., Cygler J.E., et al. Report of the AAPM Task Group No. 105: Issues associated with clinical implementation of Monte Carlo-based photon and electron external beam treatment planning. Med Phys 34 12 (2007) 4818-4853
10. Chung N.-N., Ting L.-L., Hsu W.-C., et al. Impact of magnetic resonance imaging versus CT on nasopharyngeal carcinoma: primary tumor target delineation for radiotherapy. Head & Neck 26 3 (2004) 241-246
11. Coles C., Hooles A.C.F., Harden S.V., et al. Quantitative assessment of inter-clinician variability of target volume delineation for medulloblastoma: quality assurance for the SIOP PNET 4 trial protocol. Radiother Oncol 69 (2003) 189-194
12. Emami B., Sethi A., and Petruzzelli G.J. Influence of MRI on target volume delineation and IMRT planning in nasopharyngeal carcinoma. Int J Radiation Oncology Biol Phys 57 2 (2003) 481-488
13. Fiorino C., Reni M., Bolognesi A., et al. Intra- and inter-observer variability in contouring prostate and seminal vesicles: implications for conformal treatment planning. Radiother Oncol 47 (1998) 285-292
14. Giraud P., Elles S., Helfre S., et al. Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists. Radiother Oncol 62 (2002) 27-36
15. Ratib O., Ligier Y., Mascarini C., et al. Multimedia Image and Data Navigation Workstation. Radiographics 17 2 (1997) 515-521
16. Hurkmans C.W., Borger J.H., Pieters B.R., et al. Variability in target volume delineation on CT scans of the breast. Int J Radiation Oncology Biol Phys 50 5 (2001) 1366-1372
17. International Commission on Radiation Units and Measurements. Prescribing, recording, and reporting photon beam therapy. ICRU report 50. Bethesda: ICRU; 1993.
18. International Commission on Radiation Units and Measurements. Prescribing, recording, and reporting photon beam therapy (supplement to ICRU Report 50). Report 62. Bethesda: ICRU; 1999.
19. Jeanneret-Sozzi W., Moeckli R., Valley J.-F., et al. The clinical reasons for discrepancies in target volume delineation: A SASRO study. Strahlenther Onkol 8 (2006) 450-457
20. Källman P., Agren A., and Brahme A. Tumour and normal tissue response to fractionated non-uniform dose delivery. Int J Radiat Biol 62 2 (1992) 249-262
21. Kagawa K., Lee W.R., Schultheiss T.E., et al. Initial clinical assessment of CT-MRI image fusion software in localization of the prostate for 3D conformal radiation therapy. Int J Radiation Oncology Biol Phys 38 2 (1997) 319-325
22. Ketting C.H., Austin-Seymour M., Kalet I., et al. Consistency of three-dimensional planning target volumes across physicians and institutions. Int J Radiation Oncology Biol Phys 37 2 (1997) 445-453
23. Leunens G., Menten J., Weltens C., et al. Quality assessment of medical decision making in radiation oncology: variability in target volume delineation for brain tumours. Radiother Oncol 29 (1993) 169-175
24. Logue J.P., Sharrock C.L., Cowan R.A., et al. Clinical variability of target volume description in conformal radiotherapy planning. Int J Radiation Oncology Biol Phys 41 4 (1998) 929-931
25. Lyman J.T. Complication probability as assessed from dose-volume histograms. Radiat Res 104 (1985) S13-S19
26. Miller D.W. A review of proton beam radiation therapy. Med Phys 22 11 (1995) 1943-1954
27. Milosevic M., Voruganti S., Blend R., et al. Magnetic resonance imaging (MRI) for localization of the prostatic apex: comparison to computed tomography (CT) and urethrography. Radiother Oncol 47 (1998) 277-284
28. Pitkänen M.A., Holli K.A., Ojala A.T., et al. Quality assurance in radiotherapy of breast cancer. Acta Oncol 40 (2001) 50-55
29. Rasch C., Barillot I., Remeijer P., et al. Definition of the prostate in CT and MRI: a multi-observer study. Int J Radiation Oncology Biol Phys 43 1 (1999) 57-66
30. Rasch C., Keus R., Pameijer F.A., et al. The potential impact of CT-MRI matching on tumor volume delineation in advanced head and neck cancer. Int J Radiation Oncology Biol Phys 39 4 (1997) 841-848
31. Rasch C., Remeijer P., Koper P.C.M., et al. Comparison of prostate cancer treatment in two institutions: a quality control study. Int J Radiation Oncology Biol Phys 45 4 (1999) 1055-1062
32. Ratib O., Ligier Y., and Scherrer J.R. Digital image management and communication in medicine. Computerized medical imaging and graphics 8 2 (1994) 73-84
33. Rogers D.W. Fifty years of Monte Carlo simulations for medical physics. Phys Med Biol 51 13 (2006) R287-R301
34. Seddon B., Bidmean M., Wilson J., et al. Target volume definition in conformal radiotherapy for prostate cancer: quality assurance in the MRC RT-01 trial. Radiother Oncol 56 (2000) 73-83
35. Senan S., van Sörnsen de Koste J., Samson M., et al. Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer. Radiother Oncol 53 (1999) 247-255
36. Tai P., Van Dyk J., Yu E., et al. Variability of target volume delineation in cervical esophageal cancer. Int J Radiation Oncology Biol Phys 42 2 (1998) 277-288
37. Takahaski S. Conformation radiotherapy - rotation techniques as applied to radiography and radiotherapy of cancer, Acta Radiol 1965;(Suppl. 242):S1-142.
38. Valicenti R.K., Sweet J.W., Hauck W.W., et al. Variation of clinical target volume definition in three-dimensional conformal radiation therapy for prostate cancer. Int J Radiation Oncology Biol Phys 44 4 (1999) 931-935
39. Valley J.-F., Bernier J., Tercier P.-A., et al. Quality assurance of the EORTC radiotherapy trial 22931 for head and neck carcinomas: the dummy run. Radiother Oncol 47 (1998) 37-44
40. Van de Steene J., Linthout N., de Mey J., et al. Definition of gross tumor volume in lung cancer: inter-observer variability. Radiother Oncol 62 (2002) 37-49
41. Verhaegen F., and Seuntjens J. Monte Carlo modeling of external radiotherapy photon beams. Phys Med Biol 48 21 (2003) R107-R164
42. Webb S. The physical basis of IMRT and inverse planning. British Journal of Radiology 76 (2003) 678-689
43. Weiss E., and Hess C.F. The impact of gross tumor volume (GTV) and clinical target volume (CTV) definition on the total accuracy in radiotherapy. Strahlenther Onkol 179 1 (2003) 21-30
44. Weltens C., Menten J., Feron M., et al. Interobserver variations in gross tumor volume delineation of brain tumors on computed tomography and impact of magnetic resonance imaging. Radiother Oncol 60 (2001) 49-59
45. Welsh J.S. Basics of particle therapy: introduction to hadrons. Am J Clin Oncol 31 5 (2008) 493-495
46. Widder J., Sedlmayer F., Stanek C., et al. Quality assurance in preoperative radiotherapy of rectal cancer: evaluation of a pre-trial dummy-run. Radiother Oncol 56 (2000) 341-347
47. Wu Q., Mohan R., Niemerko A., et al. Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose. IJROBP 52 1 (2002) 224-235
48. Yamamoto M., Nagata Y., Okajima K., et al. Differences in target outline delineation from CT scans of brain tumours using different methods and different observers. Radiother Oncol 50 (1999) 151-156